Biological Therapeutics Product Development Subject Matter Expert Consulting Services
Archived on August 20, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:30 AM EDT
- Posted
- August 12, 2026
- Notice type
- Sources Sought
- Set-aside
- Small Business Set Aside - Total
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NICHD
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026R00148
- Notice ID
- 0c99464f55504126ab8b9337ec351d24
Description
The National Institutes of Health (NIH), Office of the Director (OD) is conducting a market survey to determine the availability and technical capability of qualified small businesses, including 8(a) small businesses, small, disadvantaged businesses, woman-owned small businesses, service-disabled veteran-owned small businesses or HUBZone small businesses capable of providing the services of Gene-Based Therapeutics development subject matter expert (SME) consultants to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs.
Interested firms with the capability of providing all the required services shall submit a capability statement to assist the Government in determining in accordance with the Federal Acquisition Regulation 19.104-1.
The intended procurement will be classified under North American Industrial Classification (NAICS) code 541690 with a size standard of $19m. All respondents are required to identify their firm’s size and type of business. Interested firms responding to this market survey must provide (a) capability statement demonstrating their experience, skills and capability to fulfill the Government’s requirements for the above. The capability statement shall be in sufficient enough details so that the Government can determine the experience and capability of your firm to provide the items and services in this posting/notice. Offers must also be accompanied by applicable descriptive literature, delivery timeframe, warranties and other information that demonstrates that the offer meets all the foregoing requirements. Capability statements must include the name and telephone number, and email address of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to the market survey that do not provide sufficient information for evaluation will be considered non-responsive. A copy of the capability statement must be received via email to robinsti@mail.nih.gov Attn: Tina Robinson prior to 10:30 am eastern daylight time on August 19, 2026. Capability statement must reference solicitation# 75N98026R00148. Submission by email must also reference solicitation # 75N98026R00148 on the subject line of the email. Any questions must be sent via email to robinsti@mail.nih.gov and must include solicitation# 75N98026R00148 on the subject line of email. Capability statements, etc will not be returned to firm/sender. This synopsis is for information and planning purposes and is not to be construed as a commitment by the Government, nor will the Government pay for information solicited.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
Statement of Work - Biological Therapeutics.pdf
179 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchivedCurrent
Biological Therapeutics Product Development Subject Matter Expert Consulting Services
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026R00148
Archive Date
Aug 20, 2026
Office Address
BETHESDA, MD, 20817